News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle’s Know Labs bolsters exec team ahead of clinical trials for glucose monitoring device
Seattle-based company Know Labs Inc. has announced two new hires: Steven Kent as chief product officer and Peter Conley as chief financial officer and senior
Washington a big winner in tech job growth during pandemic
According to a new report from the Technology Councils of North America (TECNA), Washington state had the third-highest percentage gain in tech jobs from December
Asha AI app, which helps elderly manage their care, among startups pitching at life science event
Asha AI, a startup working to simplify healthcare tasks for the elderly, showcased its technology during the recent Life Science Washington Innovation Northwest poster session
Bill Gates helps open new vaccine manufacturing facility in Seattle area
Redmond-based biotech company, Inventprise, has opened a new Seattle-area manufacturing facility built with support from the Bill & Melinda Gates Foundation. The 700,000 square-foot facility
US pharma hubs: The rising stars to watch
A new report from CPhI North America recently named Washington state as one of this year’s top hubs driving U.S. pharma and biopharma innovation. Washington
Life sciences industry in Washington state: New trade group chief on sustaining growth and bolstering workforce
Marc Cummings, CEO of Life Science Washington, took the stage at Life Science Innovation Northwest 2022 to share his expertise in a live interview with
Life sciences news roundup: Seagen expands; biotech vet Q&A; algae capsules for gut bug; more
This year’s Life Science Washington Innovation Northwest conference brought hundreds of researchers and entrepreneurs together over two days to discuss a wide range of science
Juno Therapeutics vets Hans Bishop and Steve Harr on building startups, working with tech, and more
At Life Science Washington’s annual conference, Life Science Innovation Northwest, industry veterans Hans Bishop and Steve Harr shared their expertise on building companies and discussed
Seagen plots new biologics plant to amp up antibody drug production
Seagen announced it is building a 270,000-square-foot facility in Everett, Washington to bolster its drug manufacturing capabilities. Slated to open in 2024 just north of
BioMed Realty lays out plan for newly acquired Seattle block
BioMed Realty paid nearly $127 million for a downtown Seattle block where they seek to develop 1.2 million square feet of life science and technology
Nonprofit Seattle vaccine maker AAHI receives $26M donation
Seattle-based biotech non-profit, Access to Advanced Health Institute (AAHI) announced a $26 million donation from the Chan Soon-Shiong Family Foundation (CSSFF). The donation will be
Cell therapy biotech raises $120M to advance therapy to treat common cornea condition
Aurion Biotech, a spinoff of Seattle eye care company, CorneaGen, has received $120 million in funding to help advance cell therapy for corneal endothelial dystrophies,